310 related articles for article (PubMed ID: 29202745)
1. The association of N-terminal pro-brain-type natriuretic peptide with hemodynamics and functional capacity in therapy-naive precapillary pulmonary hypertension: results from a cohort study.
Berghaus TM; Kutsch J; Faul C; von Scheidt W; Schwaiblmair M
BMC Pulm Med; 2017 Dec; 17(1):167. PubMed ID: 29202745
[TBL] [Abstract][Full Text] [Related]
2. The association of the N-terminal pro-brain-type natriuretic peptide response to exercise with disease severity in therapy-naive pulmonary arterial hypertension: a cohort study.
Kutsch J; Faul C; von Scheidt W; Schwaiblmair M; Berghaus TM
Respir Res; 2018 Jan; 19(1):8. PubMed ID: 29334941
[TBL] [Abstract][Full Text] [Related]
3. N-terminal pro-B-type natriuretic peptide as an indicator of disease severity in a heterogeneous group of patients with chronic precapillary pulmonary hypertension.
Andreassen AK; Wergeland R; Simonsen S; Geiran O; Guevara C; Ueland T
Am J Cardiol; 2006 Aug; 98(4):525-9. PubMed ID: 16893710
[TBL] [Abstract][Full Text] [Related]
4. No changes in N-terminal pro-brain natriuretic peptide in a longitudinal cohort of patients with systemic sclerosis-associated pulmonary arterial hypertension on therapy with bosentan.
Rotondo C; Praino E; Nivuori M; di Serio F; Lapadula G; Iannone F
Int J Rheum Dis; 2017 Jan; 20(1):90-96. PubMed ID: 26218502
[TBL] [Abstract][Full Text] [Related]
5. Serum N-terminal brain natriuretic peptide as a prognostic parameter in patients with pulmonary hypertension.
Fijalkowska A; Kurzyna M; Torbicki A; Szewczyk G; Florczyk M; Pruszczyk P; Szturmowicz M
Chest; 2006 May; 129(5):1313-21. PubMed ID: 16685024
[TBL] [Abstract][Full Text] [Related]
6. MR-proADM Predicts Exercise Capacity and Survival Superior to Other Biomarkers in PH.
Kolditz M; Seyfarth HJ; Wilkens H; Ewert R; Bollmann T; Dinter C; Hertel S; Klose H; Opitz C; Grünig E; Höffken G; Halank M
Lung; 2015 Dec; 193(6):901-10. PubMed ID: 26363916
[TBL] [Abstract][Full Text] [Related]
7. Utility of B-type natriuretic peptides in the assessment of patients with systemic sclerosis-associated pulmonary hypertension in the PHAROS registry.
Chung L; Fairchild RM; Furst DE; Li S; Alkassab F; Bolster MB; Csuka ME; Derk CT; Domsic RT; Fischer A; Frech TM; Gomberg-Maitland M; Gordon JK; Hinchcliff M; Hsu V; Hummers LK; Khanna D; Medsger TAJ; Molitor JA; Preston IR; Schiopu E; Shapiro L; Hant F; Silver R; Simms R; Varga J; Steen VD; Zamanian RT
Clin Exp Rheumatol; 2017; 35 Suppl 106(4):106-113. PubMed ID: 27908301
[TBL] [Abstract][Full Text] [Related]
8. High N-terminal pro-brain natriuretic peptide levels and low diffusing capacity for carbon monoxide as independent predictors of the occurrence of precapillary pulmonary arterial hypertension in patients with systemic sclerosis.
Allanore Y; Borderie D; Avouac J; Zerkak D; Meune C; Hachulla E; Mouthon L; Guillevin L; Meyer O; Ekindjian OG; Weber S; Kahan A
Arthritis Rheum; 2008 Jan; 58(1):284-91. PubMed ID: 18163505
[TBL] [Abstract][Full Text] [Related]
9. Associations of circulating natriuretic peptides with haemodynamics in precapillary pulmonary hypertension.
Kaiser R; Grotemeyer K; Lepper P; Stokes C; Bals R; Wilkens H
Respir Med; 2015 Sep; 109(9):1213-23. PubMed ID: 26194624
[TBL] [Abstract][Full Text] [Related]
10. Exercise dependence of N-terminal pro-brain natriuretic peptide in patients with precapillary pulmonary hypertension.
Grachtrup S; Brügel M; Pankau H; Halank M; Wirtz H; Seyfarth HJ
Respiration; 2012; 84(6):454-60. PubMed ID: 22327025
[TBL] [Abstract][Full Text] [Related]
11. N-terminal pro-brain natriuretic peptide is a useful prognostic marker in patients with pre-capillary pulmonary hypertension and renal insufficiency.
Harbaum L; Hennigs JK; Baumann HJ; Lüneburg N; Griesch E; Bokemeyer C; Grünig E; Klose H
PLoS One; 2014; 9(4):e94263. PubMed ID: 24751887
[TBL] [Abstract][Full Text] [Related]
12. Comparison of brain natriuretic peptide (BNP) and NT-proBNP in screening for pulmonary arterial hypertension in patients with systemic sclerosis.
Cavagna L; Caporali R; Klersy C; Ghio S; Albertini R; Scelsi L; Moratti R; Bonino C; Montecucco C
J Rheumatol; 2010 Oct; 37(10):2064-70. PubMed ID: 20634241
[TBL] [Abstract][Full Text] [Related]
13. Plasma N-terminal pro-brain natriuretic peptide levels are positively correlated with pulmonary arterial pressure in atrial septal defect patients.
Li ZF; Zhou DX; Wang QB; Pan WZ; Zhang L; Ge JB
Regul Pept; 2013 May; 183():13-6. PubMed ID: 23499807
[TBL] [Abstract][Full Text] [Related]
14. N-terminal pro-B-type natriuretic peptide for monitoring after balloon pulmonary angioplasty for chronic thromboembolic pulmonary hypertension.
Kriechbaum SD; Wiedenroth CB; Wolter JS; Hütz R; Haas M; Breithecker A; Roller FC; Keller T; Guth S; Rolf A; Hamm CW; Mayer E; Liebetrau C
J Heart Lung Transplant; 2018 May; 37(5):639-646. PubMed ID: 29329761
[TBL] [Abstract][Full Text] [Related]
15. Baseline NT-proBNP correlates with change in 6-minute walk distance in patients with pulmonary arterial hypertension in the pivotal inhaled treprostinil study TRIUMPH-1.
Frantz RP; McDevitt S; Walker S
J Heart Lung Transplant; 2012 Aug; 31(8):811-6. PubMed ID: 22759797
[TBL] [Abstract][Full Text] [Related]
16. Correlation Between N-Terminal Pro-Brain Natriuretic Peptide Levels and Cardiopulmonary Exercise Testing in Patients With Pre-Capillary Pulmonary Hypertension: A Pilot Study.
Aueyingsak S; Khrisanapant W; Kukongviriyapun U; Pasurivong O; Ratanawatkul P; Wanitpongpan C; Pussadhamma B
Clin Med Insights Circ Respir Pulm Med; 2020; 14():1179548420954049. PubMed ID: 33117035
[TBL] [Abstract][Full Text] [Related]
17. N-terminal-pro-B type natriuretic peptide as a useful tool to evaluate pulmonary hypertension and cardiac function in CDH infants.
Baptista MJ; Rocha G; Clemente F; Azevedo LF; Tibboel D; Leite-Moreira AF; Guimarães H; Areias JC; Correia-Pinto J
Neonatology; 2008; 94(1):22-30. PubMed ID: 18160811
[TBL] [Abstract][Full Text] [Related]
18. Diaphragm function does not independently predict exercise intolerance in patients with precapillary pulmonary hypertension after adjustment for right ventricular function.
Spiesshoefer J; Herkenrath S; Mohr M; Randerath W; Tuleta I; Diller GP; Emdin M; Young P; Henke C; Florian AR; Yilmaz A; Boentert M; Giannoni A
Biosci Rep; 2019 Sep; 39(9):. PubMed ID: 31427479
[No Abstract] [Full Text] [Related]
19. N-terminal pro-brain natriuretic peptide and renal insufficiency as predictors of mortality in pulmonary hypertension.
Leuchte HH; El Nounou M; Tuerpe JC; Hartmann B; Baumgartner RA; Vogeser M; Muehling O; Behr J
Chest; 2007 Feb; 131(2):402-9. PubMed ID: 17296640
[TBL] [Abstract][Full Text] [Related]
20. NT-proBNP can be used to detect right ventricular systolic dysfunction in pulmonary hypertension.
Blyth KG; Groenning BA; Mark PB; Martin TN; Foster JE; Steedman T; Morton JJ; Dargie HJ; Peacock AJ
Eur Respir J; 2007 Apr; 29(4):737-44. PubMed ID: 17135228
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
